author-photo

Robert Schoenleber

Bayer

19

Papers

783

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer.

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (11)
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity

2007 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (131)
PDE-10A inhibitors as insulin secretagogues

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (33)
Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists: Synthesis, Structure−Activity Relationship, and In Vivo Efficacy

2007 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (47)
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (5)
Discovery of a new class of p38 kinase inhibitors

2000 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (44)
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors

2000 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (46)
A68930: A potent agonist specific for the dopamine D1 receptor

1992 Neurochemistry International
Show All
- Source
- Cite
- Save
Citations (10)
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

1992 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (140)
A 77636, A DOPAMINE (DA) D-1 RECEPTOR AGONIST WITH EFFICACY IN THE MPTP MARMOSET MODEL OF PARKINSONISM.

1992 Clinical Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (0)